HUMAX-CD20, created in 2006 (Denmark), from 10 sister brands and 2214 competing brands. HUMAX-CD20 is a brand of Genmab, listed on the stock exchange of Etats-Unis. Its International Securities Identification Number (ISIN) is DK0010272202. HUMAX-CD20 belongs to the Biotechnology business sector.

HUMAX-CD20 is a brand of Genmab (GNMSF) Share price

Share price and profitability of the share Genmab (HUMAX-CD20)

Buy Genmab share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested USD 301.00

Portfolio valuation
Genmab (HUMAX-CD20) over 5 years* USD 517.34

Stock market history Genmab (HUMAX-CD20)

Desirable brands that generate Pricing Power and therefore stock market performance

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more